Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Revenue

    Back to Income Statement
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹11,813 Cr₹11,583 Cr₹12,305 Cr₹10,944 Cr₹10,641 Cr

What is the latest Revenue of GLENMARK PHARMACEUTICALS ?

The latest Revenue ratio of GLENMARK PHARMACEUTICALS is ₹11,813 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹11,813 Cr
Mar2024₹11,583 Cr
Mar2023₹12,305 Cr
Mar2022₹10,944 Cr
Mar2021₹10,641 Cr

How is Revenue of GLENMARK PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹11,813 Cr
1.98
Mar2024 ₹11,583 Cr
-5.86
Mar2023 ₹12,305 Cr
12.44
Mar2022 ₹10,944 Cr
2.85
Mar2021 ₹10,641 Cr -

Compare Revenue of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,270.5 Cr 0.2% -1.3% 44.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,713.0 Cr -1.4% -3.2% -0.5% Stock Analytics
DIVIS LABORATORIES ₹156,811.0 Cr -1.9% -8.7% 1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,052.0 Cr -3.5% -6.6% 30.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,927.0 Cr -4% -8.3% 6.3% Stock Analytics
CIPLA ₹96,602.7 Cr -1.9% -11.9% -19% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.2%

-1.3%

44.1%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses